Oral contraceptive pill for primary dysmenorrhoea (Q24240278)

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

The cost of the menstrual cycle in young Swedish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Primary dysmenorrhea: advances in pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

A Placebo-Controlled Double-Blind Crossover Investigation of the Side Effects Attributed to Oral Contraceptives*†*Presented at the Twenty-Seventh Annual Meeting of the American Fertility Society, New Orleans, Louisiana, March 25–27, 1971.†This

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Oral contraceptive side effects: where's the beef?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Effect of various oral contraceptive combinations on dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002120.PUB3

Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.

21 January 2018

1 reference

12 December 2020

Primary dysmenorrhea.

1 reference

12 December 2020

A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives

1 reference

12 December 2020

Primary dysmenorrhea: combination vs sequential therapy.

1 reference

12 December 2020

Ibuprofen and dysmenorrhea

1 reference

12 December 2020

Treatment of functional dysmenorrhea; a double-blind study

1 reference

12 December 2020

[Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)]

1 reference

12 December 2020

A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene

1 reference

12 December 2020

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

1 reference

12 December 2020

Challenges of conducting a placebo-controlled trial for dysmenorrhea in adolescents

1 reference

12 December 2020

Tenoxicam versus lynestrenol-ethinyl estradiol treatment of dysfunctional uterine bleeding cases during adolescence

1 reference

12 December 2020

1 reference

12 December 2020

Development of the oral contraceptives

1 reference

12 December 2020

Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel

1 reference

12 December 2020

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

1 reference

12 December 2020

Oral contraceptives: side effects and depression in adolescent girls

1 reference

12 December 2020

Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea

1 reference

12 December 2020

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

1 reference

12 December 2020

Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol

1 reference

12 December 2020

Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol

1 reference

12 December 2020

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

12 December 2020

Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo

1 reference

12 December 2020

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol

1 reference

12 December 2020

Treatment of primary dysmenorrhea with a combined type oral contraceptive--a double blind study

1 reference

12 December 2020

Dysmenorrhoea unrelieved by an oral contraceptive

1 reference

12 December 2020

10.1002/14651858.CD002120.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1789808

OpenCitations bibliographic resource ID

1789808

1 reference